Clinical Trial Update: Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating high-dose vitamin C for advanced pancreatic cancer was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Vitamin C (ascorbic acid)

Snippet

Sponsor: Joseph J. Cullen | Conditions: Pancreatic Neoplasms, Pancreatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-03-29